SHOW ME:
Bradley Staats, UNC Kenan-Flagler Business School professor of operations and faculty director of the institute-affiliated Center for the Business of Health, spoke to The Well about Amazon’s next move in health care. The online retail giant announced in July that it was acquiring primary care provider One Medical and will now shut down its Amazon Care telehealth service. Staats and co-author Robert S. Huckman recently wrote in Harvard Business Review about three key components to Amazon’s playbook for entering new businesses.
Healthcare. While H.B. 149 has gotten significant media coverage related to the Medicaid expansion component, the bill includes several significant changes that will impact state health policy and the business of health in North Carolina. H.B. 149 is composed of five sections: Medicaid expansion, work requirements for certain beneficiaries, certificate of need reform, modernization of nursing regulations, and health insurance reforms.
Private equity investment in healthcare has grown over the last decade – but its role can be a hot topic. Some say PE funds innovation and streamlines costs, while others say it affects the quality of healthcare. In this week’s insight, RedSail Technologies Chief Strategy Officer Frances Nahas and Zetema Project Founder and Chair Mark Zitter to weigh in on the debate.
Amid a chaotic year both nationally and globally due to the ongoing COVID-19 pandemic and follow-on effects, private equity deals in healthcare have shown impressive resilience. According to recent research and analysis, healthcare PE deals continue to outpace all other deals – both in volume and value – with the majority of activity focused on the healthcare provider space and biopharmaceutical companies. As total healthcare deal value continues to grow, this panel paused to explore critical questions about how the growth in PE-backed healthcare companies affects patients – including their health outcomes, their medical bills and their access to important health services.
The healthcare industry experienced massive disruption in 2020 and continues to face unprecedented times. Persistent challenges presented by the ongoing COVID-19 pandemic have forced organizations to rethink their existing practices as well as how they intend to operate in future. Now more than ever, healthcare leaders need to exercise flexibility and be equipped with the right tools and ideas to lead the next generation of health.
Please join us for an exclusive conversation with Kindbody Founder and CEO Gina Bartasi on Friday, Nov. 5. This virtual fireside chat is part of the Dean’s Speaker Series, hosted by Kenan-Flagler Business School Dean Doug Shackelford. The discussion will be lead by Brad Staats, Associate Dean of MBA Programs, Professor of Operations, Sarah Graham Kenan Scholar & Faculty Director of the Center for the Business of Health.
While access and quality of healthcare in the U.S. are shaped by several factors—location, work, insurance—a simple change can make a big difference for patients. According to a new study led by the institute-affiliated Center for the Business of Health Faculty Director Brad Staats, delivering mental and physical care at the same location can improve patient experience and care efficiency. This week’s Kenan Insight offers a chance for our experts to explore the findings of this new study.
Jun 9, 2021
Turbocharging Healthcare Innovation
AI. CRISPR. mRNA. Key components of the rapidly expanding alphabet soup of technologies driving a boom in healthcare innovation. In this Kenan Insight, we explore why the 2021 Trends in Entrepreneurship Report names emerging technology in the healthcare industry as a key trend, along with some of the challenges that come with fast-moving technological advancements.
Join the Center for the Business of Health virtually as they discuss the complexity of the healthcare ecosystem and how innovation and interconnectivity are necessary to build a more robust and flexible system.
The global COVID-19 pandemic has been a recurring theme throughout the 2020 U.S. elections, and its health and economic consequences will be felt far beyond November 3. In this Kenan Insight, we look at both the challenges and potential opportunities the pandemic has created for accelerating innovations in healthcare delivery and pharmaceutical development.
The global COVID-19 pandemic has been a recurring theme throughout the 2020 U.S. elections, and its health and economic consequences will be felt far beyond November 3. In this Kenan Insight, we look at both the challenges and potential opportunities the pandemic has created for accelerating innovations in healthcare delivery and pharmaceutical development.
A panel of experts convened by UNC Kenan-Flagler Business School and its affiliated Kenan Institute of Private Enterprise will be offering a press briefing via webinar on the effects of COVID-19 on the healthcare system, its providers and supply chains. Join tomorrow, Tuesday, April 14, at 11 a.m. EDT.